Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2022.05.05
2022 FIRST QUARTERLY REPORT
2022.05.05
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2022.05.05
RESIGNATION OF EXECUTIVE DIRECTOR AND CHANGE OF FINANCIAL CONTROLLER
2022.03.31
UNAUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
2022.03.30
Date of Board Meeting
2022.03.30
(1) DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR END...
2022.03.18
DATE OF BOARD MEETING
2022.03.15
“HEPARIN SODIUM ACTIVE PHARMACEUTICAL INGREDIENT AND ENOXAPARIN SODIUM ACTIVE PH...
2022.03.02
Monthly Return 月報表
2022.01.29
PROFIT WARNING ANNOUNCEMENT ON THE ESTIMATED DECREASE IN PROFIT FOR THE ANNUAL ...
第一页
上一页
6
7
8
9
10
下一页
最后一页
